As part of our ongoing series of interviews with business leaders, ReD speaks to Britt Meelby Jensen, CEO of AMBU A/S on the importance of being customer oriented and having resilience during times of crisis.
Read More
In 2019, the global investment organization EQT acquired Karo Pharma with the ambition to build a leading Over-The-Counter healthcare provider in Northern Europe. Later that year, Christoffer Lorenzen was brought in as CEO to lead that journey. Christoffer made the transition from the bioscience company Chr. Hansen, where he had been part of leading the company’s successful growth journey.
Read More
The Covid-19 pandemic comes with a great deal of uncertainty for the healthcare industry, but it is also an unprecedented opportunity for sales and marketing leaders in the Life Sciences to take a critical look at the prevailing sales model, and redefine future interactions that are more cost-effective and high-impact.
Read More
ReD’s work with Viiv Healthcare Inspires Immersive Theatre Experience
Read More
The Helping People Heal white paper provides a deeply researched perspective on how digital is uniquely positioned to fulfill key unmet patient needs and enable warm care with individualized, adaptive, empathetic and scalable support.
Read More
Kristian Villumsen is senior vice president of global marketing for Coloplast, an international company that makes medical devices related to ostomy, urology and continence, and wound treatment.
Read More
Most companies struggle to service their customers in ways that are swift, thoughtful, and consistent.
Globalization has created more customers and more ways to interact with customers
Points of contact between companies and customers have multiplied over the years.
From the advent of penicillin to anti-cholesterol treatments, history has witnessed major developments in medicine and therapeutic offerings. At the same time, however, the prevalence of both lifestyle and chronic diseases continues to rise
Read More
The U.S., Japan and Eurozone remain the key markets for most companies, but the increasing focus on cost effectiveness and the difficulties of the general economy, make the potential for significant growth in these markets questionable. In contrast, emerging pharmaceutical markets have been growing in the double-digits and are expected to continue expanding in the years ahead, due to strong economic growth, demographic changes, and improved funding for health care.
Read More
Most of our work in health care involves new research and our approach to it always involves more than just one stakeholder, taking several stakeholders in the specific disease ecology into account. In our experience, it is through understanding different stakeholders’ perspectives that new insights can be found and new solutions developed thereafter.
Read More
Although a concern for healthcare systems for several decades, 2013 was a watershed year for obesity. Its recognition as a disease by the American Medical Association provides an opportunity to move beyond dead-end debates around personal responsibility and create renewed focus on what healthcare systems can do to treat this burgeoning epidemic.
Read More
Pharmaceutical companies should begin to take a closer look at how they create the most value for their multiple stakeholders. In the emerging world of value-based health care, the answer will increasingly go beyond a new drug.
Read More
Building on ReD’s ethnographic study of the condition, the results of a global quantitative investigation of nearly 2,000 psoriasis sufferers was recently published in the Journal of the European Academy of Dermatology and Venereology. The study’s main finding confirmed ReD’s: “the experience of the disease is as much a psychological, social, and emotional experience as a physical one”.
Read More
Over the course of 14 projects in 5 years, ReD has been responsible for helping set in motion, and for strengthening, Novo Nordisk’s commitment to the needs of diabetes patients.
Read More
ReD’s relationship with Coloplast, a Danish medical devices manufacturer, has hinged on one of the most important topics in the healthcare business today: patient compliance.
Read More